FEMASYS INC (FEMY:NASDAQ)
$2.78 0.04 (1.4599%)
Analysed FEMASYS INC (FEMY:NASDAQ) News Sources
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
08-05-2026
yahoo.com
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
13-05-2026
yahoo.com
Femasys Regains Compliance with Nasdaq Listing Requirements
24-06-2026
yahoo.com
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
07-08-2026
yahoo.com
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
12-08-2026
yahoo.com
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
19-08-2026
yahoo.com
Femasys Secures FDA Approval for Modular PMA Pathway for FemBloc
19-08-2026
advfn.com
FEMY Stock Rallies On Key Regulatory Milestone For Investigational Birth Control Technology – Retail Sees 500% Upside Potential
19-08-2026
stocktwits.com
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
19-08-2026
yahoo.com
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
26-08-2026
yahoo.com
What is the current price of FEMASYS INC (FEMY:NASDAQ)?
The current price of FEMASYS INC (FEMY:NASDAQ) is $2.78.
FEMASYS INC (FEMY:NASDAQ) absolute price change since previous trading day?
The absolute price change of FEMASYS INC (FEMY:NASDAQ) since the previous trading day is $0.04.
FEMASYS INC (FEMY:NASDAQ) percentage price change since previous trading day?
The percentage price change of FEMASYS INC (FEMY:NASDAQ) since the previous trading day is 1.4599%.
What is the most recent average sentiment score for FEMASYS INC (FEMY:NASDAQ)?
The most recent average sentiment score for FEMASYS INC (FEMY:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for FEMASYS INC (FEMY:NASDAQ)?
The most recent sentiment for FEMASYS INC (FEMY:NASDAQ) is .
SEC-8K** Filing Available For FEMASYS INC (FEMY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.